Cannabinoid receptors and the regulation of immune response.
about
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces rapid actin polymerization in HL-60 cells differentiated into macrophage-like cellsReduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptorEndocannabinoid signalling in the blood of patients with schizophreniaHigh Times for Painful Blues: The Endocannabinoid System in Pain-Depression ComorbiditySpontaneous Cannabinoid Receptor 2 (CB2) Expression in the Cochlea of Adult Albino Rat and Its Up-Regulation after Cisplatin TreatmentWhat we know and do not know about the cannabinoid receptor 2 (CB2)2-arachidonoylglycerol induces the migration of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes through the cannabinoid CB2 receptor-dependent mechanismPresence and regulation of the endocannabinoid system in human dendritic cellsCannabinoid receptor-mediated regulation of intracellular calcium by delta(9)-tetrahydrocannabinol in resting T cellsCannabinoid-receptor-independent cell signalling by N-acylethanolaminesSynthetic Cannabinoid-Induced Immunosuppression Augments Cerebellar Dysfunction in Tetanus-Toxin Treated Mice.Endocannabinoids in the dentate gyrus.A putative 'pre-nervous' endocannabinoid system in early echinoderm development.CB2: a cannabinoid receptor with an identity crisisChemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoidsCnr2 deficiency confers resistance to inflammation-induced preterm birth in mice.Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and diseaseThe role of endocannabinoids in pain modulation.Cannabinoids, loratadine and allopurinol as novel additions to the antipsoriatic ammunition.Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases.Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive propertiesCannabinoid receptor-independent actions of the aminoalkylindole WIN 55,212-2 on trigeminal sensory neuronsAssociation Study of Two Cannabinoid Receptor Genes, CNR1 and CNR2, with Methamphetamine DependenceThe cannabinoid system and immune modulation.Perinatal exposure to Δ9-tetrahydrocannabinol triggers profound defects in T cell differentiation and function in fetal and postnatal stages of life, including decreased responsiveness to HIV antigens.Modulation of inflammatory responses by a cannabinoid-2-selective agonist after spinal cord injuryCannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of NeuroinflammationFunctional selectivity in CB(2) cannabinoid receptor signaling and regulation: implications for the therapeutic potential of CB(2) ligands.CB2 cannabinoid receptor agonist, JWH-015, triggers apoptosis in immune cells: potential role for CB2-selective ligands as immunosuppressive agents.Cannabinoid 2 receptor activation reduces leukocyte adhesion and improves capillary perfusion in the iridial microvasculature during systemic inflammation.Cannabinoid receptors and their relationships with neuropsychiatric disorders.Alcohol Versus Cannabinoids: A Review of Their Opposite Neuro-Immunomodulatory Effects and Future Therapeutic PotentialsProgesterone-dependent regulation of endometrial cannabinoid receptor type 1 (CB1-R) expression is disrupted in women with endometriosis and in isolated stromal cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).Latest advances in novel cannabinoid CB(2) ligands for drug abuse and their therapeutic potential.Direct suppression of autoreactive lymphocytes in the central nervous system via the CB2 receptorDiscovery of the presence and functional expression of cannabinoid CB2 receptors in brain.Modulation of the balance between cannabinoid CB(1) and CB(2) receptor activation during cerebral ischemic/reperfusion injury.Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion modelImmunoactive effects of cannabinoids: considerations for the therapeutic use of cannabinoid receptor agonists and antagonists.
P2860
Q21245246-86087499-26B2-425A-A145-D42283691E69Q24528166-FD7ED78D-E6B4-4A20-AA5B-BE3C2A8E4828Q24672600-2D11D4A2-47D5-4FCC-A9F8-E367BBA89E39Q24800061-5C39F64B-1103-4EC7-8589-DEE8F97B9DA7Q26784030-D18A603C-63A2-4B42-AE13-AB1B4126CB51Q27324350-42013265-01CA-497C-905F-20061A79EF83Q27686851-693A7168-A717-435A-A919-8ED3B901BE02Q28200894-838FE098-57EF-45D1-8CBF-FD6A5158F7B2Q28216698-8E868FA6-4337-4AE3-8BEA-1E472DDEF4A4Q28245404-BCA55E93-02ED-4955-B7D4-3DA0BA7F637BQ28363293-8DC341E2-A571-4FFC-9D61-90AAC5435438Q33655884-C0000F5A-18CE-4BEB-A764-324BBDFC6BE5Q33757950-6388D761-DE7D-4953-87EC-46567DB68094Q33837421-C2F6582C-AFDF-41C5-BD09-F1C8A351B1FAQ34098185-7FA9D776-F19F-423A-A632-21A08CE59F9FQ34156640-A34428CD-6265-4D60-86E1-60158D4A0CEDQ34185758-BFA99479-865A-437D-86C2-1ACBB3559D1AQ34188446-64A2C807-D753-46CC-BCFE-0015325EBA87Q34320270-183909D4-8046-4518-AFFB-9AB302E99E06Q34414281-B39A83BC-86BD-4E16-A9EA-4BA37E83B80AQ34454367-B365A08A-0392-4EE9-A860-24D6C2EFBCBFQ34789214-929587F8-6E69-45B8-88AE-A9FE378E79E0Q35047139-8A1F084E-A8B5-40BF-A793-8737E3ACC4A1Q35107801-EB7CC071-3D67-41E0-AD50-863FA03DF25CQ35213813-9E4603A1-C2AA-4B98-8F44-14A6F02F3FEAQ35429696-0A473E1E-22CA-4974-9C1B-43D7BBB6E681Q35606180-9DC2A71C-AB1D-4BA8-9929-8E6AFE9C4C2CQ35667387-93083896-D30B-481C-AA97-671B4D8A122EQ35688511-628976EA-65E3-4345-AB9C-574B0EFCFAF4Q35781582-1056F5D3-93B9-40CB-ADA9-746FD66BCA5FQ35789673-A7C85B2D-6B17-43CB-B357-F486E8FF5704Q36033414-74D4CF69-3B33-47EF-868C-785695C617B7Q36165438-E87532CE-965C-4831-B759-5DB319A9AD2BQ36291274-29B04614-4EF3-43C6-A639-01F0BE5163C1Q36408464-7F186A6E-1C36-4689-AA37-5038D6432782Q36416340-F4028A85-DE6B-4CF4-BCED-A388F7A98860Q36653994-58EEE862-C089-43BE-A5CD-358B07B46489Q36961126-F5E36421-2474-4B96-A699-B4AFFD17F9DDQ37087780-B4452AEA-E079-4E79-A8B1-63A0803C946AQ37244823-EBD719D2-309B-4FD1-AD3F-DCCBD09FE89A
P2860
Cannabinoid receptors and the regulation of immune response.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Cannabinoid receptors and the regulation of immune response.
@ast
Cannabinoid receptors and the regulation of immune response.
@en
Cannabinoid receptors and the regulation of immune response.
@nl
type
label
Cannabinoid receptors and the regulation of immune response.
@ast
Cannabinoid receptors and the regulation of immune response.
@en
Cannabinoid receptors and the regulation of immune response.
@nl
prefLabel
Cannabinoid receptors and the regulation of immune response.
@ast
Cannabinoid receptors and the regulation of immune response.
@en
Cannabinoid receptors and the regulation of immune response.
@nl
P1476
Cannabinoid receptors and the regulation of immune response.
@en
P2093
Berdyshev EV
P304
P356
10.1016/S0009-3084(00)00195-X
P577
2000-11-01T00:00:00Z